Issue 1 - October 2009 - Introduction to the Essential Medicines Monitor - Results of the Monitor readership survey - Adherence to antiretroviral therapy
Issue 2 - November 2009 - We return to the subject of ARV adherence as Richard Lester and Antony Kariri report on a study of the effects of using text messaging
- Felix Yellu describes how Ghana has adapted WHO guidelines to create a monitoring system that helps to keep track of medicines availability and accessibility throughout the country
- Michael Albert discusses policy-makers' use of research findings when creating or updating an essential medicines list
Issue 3 - March 2010 - Aviva Ron and colleagues report on a study involving out-patients in eight hospitals in Lao People's Democratic Republic. The study compared prescribing for patients who belong to a community-based health insurance scheme with that for non-insured patients
- Lisa Hayes gives details of a manual that is being developed to help medical and pharmacy students learn how to assess pharmaceutical promotion
- Our regular Published Lately section helps you to catch up on new WHO publications related to medicines
Issue 4 - April 2010 - Medicine price surveys using the WHO/Health Action International methodology have been carried out in many countries as has been reported in previous issues of the Monitor. Here we publish details of a survey in Brazil, which provides useful tips for others on how to avoid some possible pitfalls.
- The Medicines Transparency Alliance (MeTA) reports on work plan implementation in countries. In Uganda, for example, MeTA has helped the National Drug Authority to make the database of registered medicines available on its web site, while MeTA Peru has focused its efforts on developing a Price Observatory to give the public access to accurate information about medicine prices.
Issue 5 - August 2011 - Responding to the low level of availability and affordability of asthma medicines in many low- and middle-income countries, the International Union Against Tuberculosis and Lung Disease created the Asthma Drug Facility (ADF) with the mission to provide access to quality assured essential asthma medicines. This article discusses how the ADF works and the benefits being experienced at country level.
- A National Monitoring Network on Clinical Antibiotics Use was established in China in 2005, to monitor the volume and patterns of antibiotic use and the impact of control measures. When the 2006-2007 monitoring report showed that the proportion of irrational antibiotic use in surgical practice was widespread and serious, the Ministry of Health initiated an intervention project to promote rational antibiotic prophylaxis in clean surgeries. Learn more about the effects of the three rounds of interventions carried out between 2008 and 2009.